Global Stented Biological Valve 麻豆原创 Research Report 2025

Publication ID:

PB505254052

Publication Date:

May 19, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Stented Biological Valve was valued at US$ 3026 million in the year 2024 and is projected to reach a revised size of US$ 4523 million by 2031, growing at a CAGR of 5.9% during the forecast period.
A Stented Biological Valve is a type of bioprosthetic heart valve that incorporates a metallic or polymeric stent to hold the valve in place. These valves are made from animal tissues (bovine or porcine) and are designed for patients who require a valve replacement but do not wish to take long-term anticoagulants.
麻豆原创 Overview:
Stented biological valves are among the most commonly used valves in heart valve replacement surgeries. They are widely used due to their natural function, low risk of thromboembolic events, and favorable clinical outcomes. The addition of a stent allows for easier implantation, particularly in older patients and those undergoing transcatheter procedures.
麻豆原创 Drivers:
Preference for biological valves over mechanical valves due to their natural function and reduced need for anticoagulation.
Increasing adoption of minimally invasive approaches like TAVR, where stented biological valves are often preferred.
Aging populations and the rising incidence of valvular heart disease.
麻豆原创 Opportunities:
Expanding indications for the use of stented biological valves in various procedures, particularly in lower-risk patient populations.
Research into improving the longevity and anti-calcification properties of stented valves.
麻豆原创 Limitations:
Limited durability compared to mechanical valves, which may require reoperation in younger patients.
Concerns about the risk of degeneration and calcification, particularly in patients under 65 years old.
麻豆原创 Trends:
Greater adoption of TAVR procedures, leading to a rise in the use of stented biological valves.
Ongoing improvements in the durability and biocompatibility of stented biological valves.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stented Biological Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stented Biological Valve.
The Stented Biological Valve market size, estimations, and forecasts are provided in terms of sales volume (Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stented Biological Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stented Biological Valve manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Edwards Lifesciences
St. Jude Medical
Meril Life Sciences
Boston Scientific
Labor
Abbott
Colibri Heart Valve
Balance Medical
Venus Medtech
Suzhou Jiecheng Medical Technology
Segment by Type
Surgical Valve
Interventional Valve
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Stented Biological Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Stented Biological Valve in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Stented Biological Valve 麻豆原创 Overview
1.1 Product Definition
1.2 Stented Biological Valve by Type
1.2.1 Global Stented Biological Valve 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Surgical Valve
1.2.3 Interventional Valve
1.3 Stented Biological Valve by Application
1.3.1 Global Stented Biological Valve 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Stented Biological Valve 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Stented Biological Valve Revenue 2020-2031
1.4.2 Global Stented Biological Valve Sales 2020-2031
1.4.3 Global Stented Biological Valve 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Stented Biological Valve 麻豆原创 Competition by Manufacturers
2.1 Global Stented Biological Valve Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Stented Biological Valve Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Stented Biological Valve Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Stented Biological Valve, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Stented Biological Valve, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Stented Biological Valve, Product Type & Application
2.7 Global Key Manufacturers of Stented Biological Valve, Date of Enter into This Industry
2.8 Global Stented Biological Valve 麻豆原创 Competitive Situation and Trends
2.8.1 Global Stented Biological Valve 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Stented Biological Valve Players 麻豆原创 Share by Revenue
2.8.3 Global Stented Biological Valve Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Stented Biological Valve 麻豆原创 Scenario by Region
3.1 Global Stented Biological Valve 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Stented Biological Valve Sales by Region: 2020-2031
3.2.1 Global Stented Biological Valve Sales by Region: 2020-2025
3.2.2 Global Stented Biological Valve Sales by Region: 2026-2031
3.3 Global Stented Biological Valve Revenue by Region: 2020-2031
3.3.1 Global Stented Biological Valve Revenue by Region: 2020-2025
3.3.2 Global Stented Biological Valve Revenue by Region: 2026-2031
3.4 North America Stented Biological Valve 麻豆原创 Facts & Figures by Country
3.4.1 North America Stented Biological Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Stented Biological Valve Sales by Country (2020-2031)
3.4.3 North America Stented Biological Valve Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Stented Biological Valve 麻豆原创 Facts & Figures by Country
3.5.1 Europe Stented Biological Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Stented Biological Valve Sales by Country (2020-2031)
3.5.3 Europe Stented Biological Valve Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Stented Biological Valve 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Stented Biological Valve 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Stented Biological Valve Sales by Region (2020-2031)
3.6.3 Asia Pacific Stented Biological Valve Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Stented Biological Valve 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Stented Biological Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Stented Biological Valve Sales by Country (2020-2031)
3.7.3 Latin America Stented Biological Valve Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Stented Biological Valve 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Stented Biological Valve 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Stented Biological Valve Sales by Country (2020-2031)
3.8.3 Middle East and Africa Stented Biological Valve Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Stented Biological Valve Sales by Type (2020-2031)
4.1.1 Global Stented Biological Valve Sales by Type (2020-2025)
4.1.2 Global Stented Biological Valve Sales by Type (2026-2031)
4.1.3 Global Stented Biological Valve Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Stented Biological Valve Revenue by Type (2020-2031)
4.2.1 Global Stented Biological Valve Revenue by Type (2020-2025)
4.2.2 Global Stented Biological Valve Revenue by Type (2026-2031)
4.2.3 Global Stented Biological Valve Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Stented Biological Valve Price by Type (2020-2031)
5 Segment by Application
5.1 Global Stented Biological Valve Sales by Application (2020-2031)
5.1.1 Global Stented Biological Valve Sales by Application (2020-2025)
5.1.2 Global Stented Biological Valve Sales by Application (2026-2031)
5.1.3 Global Stented Biological Valve Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Stented Biological Valve Revenue by Application (2020-2031)
5.2.1 Global Stented Biological Valve Revenue by Application (2020-2025)
5.2.2 Global Stented Biological Valve Revenue by Application (2026-2031)
5.2.3 Global Stented Biological Valve Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Stented Biological Valve Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Stented Biological Valve Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Edwards Lifesciences
6.2.1 Edwards Lifesciences Company Information
6.2.2 Edwards Lifesciences Description and Business Overview
6.2.3 Edwards Lifesciences Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Edwards Lifesciences Stented Biological Valve Product Portfolio
6.2.5 Edwards Lifesciences Recent Developments/Updates
6.3 St. Jude Medical
6.3.1 St. Jude Medical Company Information
6.3.2 St. Jude Medical Description and Business Overview
6.3.3 St. Jude Medical Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.3.4 St. Jude Medical Stented Biological Valve Product Portfolio
6.3.5 St. Jude Medical Recent Developments/Updates
6.4 Meril Life Sciences
6.4.1 Meril Life Sciences Company Information
6.4.2 Meril Life Sciences Description and Business Overview
6.4.3 Meril Life Sciences Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Meril Life Sciences Stented Biological Valve Product Portfolio
6.4.5 Meril Life Sciences Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Company Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boston Scientific Stented Biological Valve Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Labor
6.6.1 Labor Company Information
6.6.2 Labor Description and Business Overview
6.6.3 Labor Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Labor Stented Biological Valve Product Portfolio
6.6.5 Labor Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Stented Biological Valve Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Colibri Heart Valve
6.8.1 Colibri Heart Valve Company Information
6.8.2 Colibri Heart Valve Description and Business Overview
6.8.3 Colibri Heart Valve Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Colibri Heart Valve Stented Biological Valve Product Portfolio
6.8.5 Colibri Heart Valve Recent Developments/Updates
6.9 Balance Medical
6.9.1 Balance Medical Company Information
6.9.2 Balance Medical Description and Business Overview
6.9.3 Balance Medical Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Balance Medical Stented Biological Valve Product Portfolio
6.9.5 Balance Medical Recent Developments/Updates
6.10 Venus Medtech
6.10.1 Venus Medtech Company Information
6.10.2 Venus Medtech Description and Business Overview
6.10.3 Venus Medtech Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Venus Medtech Stented Biological Valve Product Portfolio
6.10.5 Venus Medtech Recent Developments/Updates
6.11 Suzhou Jiecheng Medical Technology
6.11.1 Suzhou Jiecheng Medical Technology Company Information
6.11.2 Suzhou Jiecheng Medical Technology Description and Business Overview
6.11.3 Suzhou Jiecheng Medical Technology Stented Biological Valve Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Suzhou Jiecheng Medical Technology Stented Biological Valve Product Portfolio
6.11.5 Suzhou Jiecheng Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Stented Biological Valve Industry Chain Analysis
7.2 Stented Biological Valve Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Stented Biological Valve Production Mode & Process Analysis
7.4 Stented Biological Valve Sales and 麻豆原创ing
7.4.1 Stented Biological Valve Sales Channels
7.4.2 Stented Biological Valve Distributors
7.5 Stented Biological Valve Customer Analysis
8 Stented Biological Valve 麻豆原创 Dynamics
8.1 Stented Biological Valve Industry Trends
8.2 Stented Biological Valve 麻豆原创 Drivers
8.3 Stented Biological Valve 麻豆原创 Challenges
8.4 Stented Biological Valve 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Medtronic
Edwards Lifesciences
St. Jude Medical
Meril Life Sciences
Boston Scientific
Labor
Abbott
Colibri Heart Valve
Balance Medical
Venus Medtech
Suzhou Jiecheng Medical Technology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.